Refer to Section 3 of the full guidance.
The following best practice advice is based on clinical experience and expert opinion.
Assessing the bleeding risk for a patient taking anticoagulants or antiplatelet drugs involves consideration of both:
While the risk of bleeding complications associated with dental treatment for these patients should always be considered, it should be noted that existing evidence and clinical experience suggest that serious adverse bleeding events are rare.